Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis-Reference-Cited by-同舟云学术

Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis

Published:2021-02-09 Issue:8 Volume:32 Page:1621-1629
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Hamar A.,Szekanecz Z.^ORCID,Pusztai A.,Czókolyová M.,Végh E.,Pethő Z.,Bodnár N.,Gulyás K.,Horváth Á.,Soós B.,Bodoki L.,Bhattoa H. P.,Nagy G.,Tajti G.,Panyi G.,Szekanecz É.,Domján A.,Hodosi K.,Szántó S.,Szűcs G.,Szamosi S.

Funder

European Union

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-021-05871-0.pdf

Reference41 articles.

1. Lems WF, Dijkmans BA (1998) Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis 57:325–327

2. Szentpetery A, Horvath A, Gulyas K, Petho Z, Bhattoa HP, Szanto S, Szucs G, FitzGerald O, Schett G, Szekanecz Z (2017) Effects of targeted therapies on the bone in arthritides. Autoimmun Rev 16:313–320

3. Deal C (2012) Bone loss in rheumatoid arthritis: systemic, periarticular, and focal. Curr Rheumatol Rep 14:231–237

4. Schett G, Gravallese E (2012) Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol 8:656–664

5. Rotta D, Fassio A, Rossini M, Giollo A, Viapiana O, Orsolini G, Bertoldo E, Gatti D, Adami G (2020) Osteoporosis in inflammatory arthritides: new perspective on pathogenesis and treatment. Front Med 7:613720

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis;BMC Rheumatology;2024-09-10

2. Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal–regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice;Bone;2024-04

3. Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis;2024-03-29

4. The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches;Clinical Rheumatology;2024-03-18

5. Pathogenesis, assessment, and management of bone loss in axial spondyloarthritis;Seminars in Arthritis and Rheumatism;2024-02